2m 2m 2m 2m 2m 2m 2m
BioAtla (BCAB)
NASDAQ
$3.36-$0.17 (-4.96%)
Price as of Jun 03, 2026 6:35 PM EDT- $6.5MMarket Cap
- -86.50%1-Year Change
- BiotechnologyIndustry
BioAtla (BCAB)
$3.36-$0.17 (-4.96%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.0M -81.82% | 11.0M N/A | 0 N/A | 0 -100.00% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 2.0M -81.82% | 11.0M N/A | 0 N/A | 0 -100.00% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -43.6M -30.94% | -63.1M -39.17% | -103.7M +30.73% | -79.3M +36.16% | |
Depreciation and Amortization Expense | 373,000 -59.68% | 925,000 -24.24% | 1.2M +1.83% | 1.2M -9.85% | |
Total Operating Expenses | 61.3M -27.83% | 84.9M -34.50% | 129.7M +19.93% | 108.1M +11.84% | |
Operating Profit | -59.3M -19.80% | -73.9M -42.98% | -129.7M +19.93% | -108.1M +12.13% | |
Interest Income | 843,000 -74.98% | 3.4M -46.63% | 6.3M +283.01% | 1.6M +370.86% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | 0 +100.00% | |
Interest Income and Expense and Net | 843,000 -74.98% | 3.4M -46.63% | 6.3M +283.01% | 1.6M +374.93% | |
Total Nonoperating Income and Expense | -1.0M +11,388.89% | -9,000 -89.66% | -87,000 -970.00% | 10,000 +900.00% | |
Income before Taxes | -59.3M -19.80% | -73.9M -42.98% | -129.7M +19.93% | -108.1M +12.13% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -59.6M -14.57% | -69.8M -43.48% | -123.5M +15.95% | -106.5M +11.61% | |
Net Income from Continuing Operations Applicable to Common | -59.6M -14.57% | -69.8M -43.48% | -123.5M +15.95% | -106.5M +11.61% | |
Basic EPS and Net Income | -1.01 -29.86% | -1.44 -44.19% | -2.58 -5.84% | -2.74 -0.72% | |
Diluted EPS and Net Income | -1.01 -29.86% | -1.44 -44.19% | -2.58 -5.84% | -2.74 -0.72% | |
Basic Weighted Average Shares | 58.8M +21.11% | 48.6M +1.67% | 47.8M +22.74% | 38.9M +12.63% | |
Diluted Weighted Average Shares | 58.8M +21.11% | 48.6M +1.67% | 47.8M +22.74% | 38.9M +12.63% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 7.1M -85.49% | 49.0M -56.00% | 111.5M -48.27% | 215.5M -12.03% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 7.1M -85.49% | 49.0M -56.00% | 111.5M -48.27% | 215.5M -12.03% | |
Total Current Assets | 8.0M -84.36% | 51.2M -55.99% | 116.4M -47.19% | 220.4M -10.86% | |
Accumulated Depreciation | 5.3M -24.20% | 7.0M +15.22% | 6.1M +13.31% | 5.4M +26.00% | |
Property and Plant and Equipment and Net | 120,000 -82.30% | 678,000 -57.70% | 1.6M -41.24% | 2.7M -25.79% | |
Total Long-Term Assets | 163,000 N/A | 0 -100.00% | 154,000 0.00% | 154,000 0.00% | |
Total Assets | 13.8M -73.62% | 52.4M -56.19% | 119.7M -46.99% | 225.7M -11.27% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 21.9M +50.77% | 14.5M -48.70% | 28.3M +22.54% | 23.1M +16.75% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 8.3M +117.50% | 3.8M +355.86% | 836,000 -66.02% | 2.5M -38.22% | |
Total Liabilities | 50.0M +31.08% | 38.2M -22.11% | 49.0M +7.91% | 45.4M +4.12% | |
Retained Earnings | -545.6M +12.26% | -486.0M +16.76% | -416.3M +42.17% | -292.8M +57.15% | |
Total Stockholders Equity | -36.2M -353.69% | 14.3M -79.82% | 70.7M -60.81% | 180.3M -14.46% | |
Total Shares Outstanding | 63.5M +9.23% | 58.1M +20.84% | 48.1M +3.76% | 46.3M +29.43% | |
Cash Flow | |||||
Cash from Operating Activities | -48.2M -32.99% | -71.9M -30.84% | -104.0M +15.04% | -90.4M +45.34% | |
Capital Expenditures | N/A N/A | 0 -100.00% | 98,000 -63.43% | 268,000 -71.00% | |
Cash from Investing Activities | N/A N/A | 0 +100.00% | -98,000 -63.02% | -265,000 -71.32% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 6.3M -34.01% | 9.5M +12,251.95% | 77,000 -99.87% | 61.2M -11.94% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -2,965.25% +341.12% | -672.21% N/A | N/A N/A | N/A N/A | |
Return on Assets | -179.95% +121.89% | -81.10% +13.44% | -71.49% +61.19% | -44.35% N/A | |
Return on Equity | 543.76% +430.95% | -164.30% +67.02% | -98.37% +80.68% | -54.44% N/A | |
Revenue Growth | -81.82% N/A | N/A N/A | N/A N/A | -100.00% N/A | |
Current Ratio | 0.37 -89.63% | 3.52 -14.21% | 4.11 -56.90% | 9.53 N/A | |
Cash Ratio | 0.32 -90.37% | 3.37 -14.23% | 3.93 -57.79% | 9.32 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow